• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Pharmaceutical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Special Issue
Issue Issue 1
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Bavand Savadkouhi, M., Vahidi, H., Ayatollahi, A., Hooshfar, S., Kobarfard, F. (2017). RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms. Iranian Journal of Pharmaceutical Research, 16(2), 490-497. doi: 10.22037/ijpr.2017.2019
Maryam Bavand Savadkouhi; Hossein Vahidi; Abdul Majid Ayatollahi; Shirin Hooshfar; Farzad Kobarfard. "RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms". Iranian Journal of Pharmaceutical Research, 16, 2, 2017, 490-497. doi: 10.22037/ijpr.2017.2019
Bavand Savadkouhi, M., Vahidi, H., Ayatollahi, A., Hooshfar, S., Kobarfard, F. (2017). 'RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms', Iranian Journal of Pharmaceutical Research, 16(2), pp. 490-497. doi: 10.22037/ijpr.2017.2019
Bavand Savadkouhi, M., Vahidi, H., Ayatollahi, A., Hooshfar, S., Kobarfard, F. RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms. Iranian Journal of Pharmaceutical Research, 2017; 16(2): 490-497. doi: 10.22037/ijpr.2017.2019

RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms

Article 10, Volume 16, Issue 2, Spring 2017, Page 490-497  XML PDF (437.26 K)
Document Type: Research article
DOI: 10.22037/ijpr.2017.2019
Authors
Maryam Bavand Savadkouhi1; Hossein Vahidi2; Abdul Majid Ayatollahi3; Shirin Hooshfar4; Farzad Kobarfard email orcid 5
1Department of pharmaceutical biotechnology, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran Students research committee, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran
2Department of pharmaceutical biotechnology, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran
3Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5-
Abstract
A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 column (150 x 4.60 mm i.d., 5µm particle size) at ambient temperature using acetonitrile (ACN), water and trifluoroacetic acid (TFA) as mobile phase at flow rate of 1 ml/min and UV detection at 275 nm. Eptifibatide acetate exhibited linearity over the concentration range of 0.15-2 mg/ml (r2=0.997) with limit of detection of 0.15 mg/ml. The accuracy of the method was 96.4-103.8%. The intra-day and inter-day precision were between 0.052% and 0.598%, respectively. The present successfully validated method with excellent selectivity, linearity, sensitivity, precision and accuracy was applicable for the assay of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms.
Keywords
Eptifibatide acetate; HPLC-UV; Determination; Drug substance; Formulation
Main Subjects
Drug quality control
Statistics
Article View: 2,164
PDF Download: 24,700
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.